Medicare Enrolled

Amanda Merritt, ANP

Nurse Practitioner - Adult Health · Savannah, GA
6602 WATERS AVE BLDG C, Savannah, GA 31406
9123547676
Registered in NPPES since 2009
NPI: 1679801534 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Merritt from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Merritt? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Merritt

Amanda Merritt is a nurse practitioner - adult health in Savannah, GA, with 16 years of NPI registration.

Between the years covered by Open Payments, Merritt received a total of $13,122 from 65 pharmaceutical and/or device companies across 672 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Merritt is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration $13,122 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$13,122
Total received (2021-2024)
Avg $3,281/year across 4 years
Top 1% in GA for nurse practitioner - adult health
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
65
Companies
672
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,618
2023
$3,370
2022
$2,775
2021
$2,359

Payments by company (2024)

LivaNova USA, Inc.
$1,733
ABBVIE INC.
$498
UCB, Inc.
$270
Lundbeck LLC
$186
Novartis Pharmaceuticals Corporation
$165
Biogen, Inc.
$155
SK Life Science, Inc.
$135
PFIZER INC.
$118
Mallinckrodt Hospital Products Inc.
$110
Alexion Pharmaceuticals, Inc.
$105
Neurocrine Biosciences, Inc.
$100
Takeda Pharmaceuticals U.S.A., Inc.
$88
CATALYST PHARMACEUTICALS, INC.
$85
Ipsen Biopharmaceuticals, Inc
$77
ARGENX US, INC.
$68
Eisai Inc.
$64
Neurelis, Inc.
$61
JAZZ PHARMACEUTICALS INC.
$61
SCILEX PHARMACEUTICALS INC.
$57
EMD Serono, Inc.
$56
Celgene Corporation
$55
Averitas Pharma Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
Lilly USA, LLC
$37
Otsuka America Pharmaceutical, Inc.
$36
TG Therapeutics, Inc.
$36
Sumitomo Pharma America, Inc.
$35
Genentech USA, Inc.
$34
Kyowa Kirin, Inc.
$30
Sandoz Inc.
$28
CSL Behring
$25
Teva Pharmaceuticals USA, Inc.
$22
InSightec,Inc
$14
Top 3 companies account for 54.2% of 2024 payments
All-time payments by company (2021-2024) ›
LivaNova USA, Inc.
$1,757
ABBVIE INC.
$1,365
Biogen, Inc.
$1,084
UCB, Inc.
$674
Mallinckrodt Hospital Products Inc.
$636
Novartis Pharmaceuticals Corporation
$542
EMD Serono, Inc.
$463
SK Life Science, Inc.
$435
Neurelis, Inc.
$426
JAZZ PHARMACEUTICALS INC.
$426
Teva Pharmaceuticals USA, Inc.
$357
Lundbeck LLC
$349
Ipsen Biopharmaceuticals, Inc
$339
Alexion Pharmaceuticals, Inc.
$264
PFIZER INC.
$252
AbbVie Inc.
$247
Sumitomo Pharma America, Inc.
$222
ARGENX US, INC.
$215
Eisai Inc.
$215
Neurocrine Biosciences, Inc.
$210
Allergan, Inc.
$198
Biohaven Pharmaceutical Holding Company Ltd.
$184
Sunovion Pharmaceuticals Inc.
$165
Amgen Inc.
$156
Genentech USA, Inc.
$131
Merz Pharmaceuticals, LLC
$122
Janssen Pharmaceuticals, Inc
$116
Otsuka America Pharmaceutical, Inc.
$115
Takeda Pharmaceuticals U.S.A., Inc.
$110
Biohaven Pharmaceuticals, Inc.
$94
CATALYST PHARMACEUTICALS, INC.
$85
Celgene Corporation
$82
CSL Behring
$63
Harmony Biosciences LLC
$63
Kyowa Kirin, Inc.
$60
Alnylam Pharmaceuticals Inc.
$58
Catalyst Pharmaceuticals, Inc.
$57
SCILEX PHARMACEUTICALS INC.
$57
HOSPIRA, INC.
$46
Scilex Pharmaceuticals Inc.
$42
IMPEL PHARMACEUTICALS INC.
$41
Horizon Therapeutics plc
$40
Sarepta Therapeutics, Inc.
$39
EISAI INC.
$39
Averitas Pharma Inc.
$38
AstraZeneca Pharmaceuticals LP
$37
Lilly USA, LLC
$37
TG Therapeutics, Inc.
$36
AQUESTIVE THERAPEUTICS, INC.
$34
Sandoz Inc.
$28
MITSUBISHI TANABE PHARMA AMERICA, INC.
$27
HARMONY BIOSCIENCES LLC
$27
Amylyx Pharmaceuticals, Inc.
$23
BANNER LIFE SCIENCES, LLC
$22
Azurity Pharmaceuticals, Inc.
$20
GRT US Holding, Inc.
$20
Marinus Pharmaceuticals, Inc.
$17
ACADIA Pharmaceuticals Inc
$16
GENZYME CORPORATION
$16
BOSTON SCIENTIFIC CORPORATION
$16
Avanir Pharmaceuticals, Inc.
$16
Corium, LLC
$15
InSightec,Inc
$14
Acorda Therapeutics, Inc
$13
Medtronic, Inc.
$12
Top 3 companies account for 32.0% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · AMYVID · APTIOM · AUSTEDO · AVONEX · Aimovig · Azstarys · BAFIERTAM · BOTOX · BRIUMVI · Briviact · DUOPA · DYSPORT · Dysport · ELYXYB - CELECOXIB · EPIDIOLEX · Enspryng · Eprontia · Evrysdi · Exablate · Exondys 51 · FYCOMPA · Fintepla · Fycompa · GAMMAGARD · GENERAL PAIN MANAGEMENT · GILENYA · HYQVIA · Hizentra · INBRIJA · INGREZZA · KESIMPTA · KYNMOBI · LINQ II · Leqembi · MAVENCLAD · Mavenclad · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Nourianz · Nuedexta · OCREVUS · ONPATTRO · Ocrevus · Ongentys · PANZYGA · PLEGRIDY · Ponvory · QULIPTA · QUTENZA · Qutenza · RADICAVA · RELYVRIO · REXULTI · Rystiggo · SKYCLARYS · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Soliris · TECFIDERA · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAINUA · WAKIX · Wakix · XYWAV · Xeomin · ZEPOSIA · ZTALMY · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a nurse practitioner - adult health in Savannah?
Compare adult-health nurse practitioners in the Savannah area by procedure volume, costs, and industry payment transparency.
Browse adult-health nurse practitioners nearby

Geographic Context

Adult-health nurse practitioners in nearby ZIP areas
48
County median income
$69,575
Nearest hospital to ZIP centroid (approximate)
COASTAL HARBOR TREATMENT CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Merritt is a nurse practitioner - adult health, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Merritt receive payments from pharmaceutical companies?
Yes. Merritt received a total of $13,122 from 65 companies across 672 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Merritt) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →